Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
Page 1 of 1
Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
Jon Moulton Tue Mar 10, 2015 9:43 am
Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Schötterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz K-L, Gawaz MP, Moretti A. Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Mol Med. 2015;[Epub ahead of print] doi:10.15252/emmm.201505047
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
» Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
» Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
» Antisense oligo-mediated multiple exon skipping in a dog model of duchenne muscular dystrophy
» Repurposing Dantrolene for Long-term Combination Therapy to Potentiate Antisense-Mediated DMD Exon-Skipping in the mdx mouse
» Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
» Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
» Antisense oligo-mediated multiple exon skipping in a dog model of duchenne muscular dystrophy
» Repurposing Dantrolene for Long-term Combination Therapy to Potentiate Antisense-Mediated DMD Exon-Skipping in the mdx mouse
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum